Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
94.73
+0.13 (0.14%)
Nov 21, 2024, 10:59 AM EST - Market open
Axsome Therapeutics Employees
Axsome Therapeutics had 545 employees as of December 31, 2023. The number of employees increased by 162 or 42.30% compared to the previous year.
Employees
545
Change (1Y)
162
Growth (1Y)
42.30%
Revenue / Employee
$621,022
Profits / Employee
-$570,560
Market Cap
4.61B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Integer Holdings | 10,500 |
Stevanato Group | 5,634 |
Alkermes | 2,100 |
Ultragenyx Pharmaceutical | 1,276 |
PROCEPT BioRobotics | 626 |
BridgeBio Pharma | 556 |
TG Therapeutics | 264 |
AXSM News
- 8 days ago - Axsome Therapeutics, Inc. (AXSM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Axsome Therapeutics Q3 Earnings: Stay For The Near Term Catalysts, Then Sell - Seeking Alpha
- 13 days ago - Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024 - GlobeNewsWire
- 23 days ago - Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024 - GlobeNewsWire
- 5 weeks ago - Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12 - GlobeNewsWire
- 2 months ago - Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine - GlobeNewsWire
- 3 months ago - Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc. - GlobeNewsWire
- 3 months ago - Axsome's Auvelity: High Hopes Meet Hefty Bills (Rating Downgrade) - Seeking Alpha